Primary N-hydroxylamines
US6455589B1 · kind B1 · utility
32Cited by
7References
58Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 28, 1999 |
| Grant date | Sep 24, 2002 |
| Priority date | — |
| Expiry date | Oct 28, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/47
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides pharmaceutical compositions comprising primary N-hydroxylamines and related therapeutic, prophylactic, diagnostic and screening methods. The pharmaceutical compositions generally comprise a pharmaceutical composition comprising an orally administrable effective unit solid dosage of a primary N-hydroxylamine or a pharmaceutically acceptable salt thereof and substantially free of a nitrone corresponding to the hydroxylamine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.